714 Followers on Owler

Sangamo

focuses on research, development and commercialization of deoxyribonucleic acid binding proteins for therapeutic gene regulation... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Sangamo

focuses on research, development and commercialization of deoxyribonucleic acid binding proteins for therapeutic gene regulation... Read more
Sangamo President & CEO: Sandy Macrae

President & CEO

Sandy Macrae

CEO Approval Rating

68/100

1995

PublicNASDAQSGMO

Pharmaceuticals & Biotechnology
Biotechnology
283687312834 NAICS listing

Annual Revenue
$57.8M
Employees
480
Funding
$71.5M
Acquisitions
2

News

Partnership
Feb 21, 2025
BioSpace
Pfizer Axes Beqvez Worldwide, Pivoting Away From Gene Therapy for Hemophilia

Sangamo Competitors

1uniQure
2Regenxbio
3Asklepios
4Renova Therapeutics
5Dimension Therapeutics
6InterMune
7Lysogene
8Calimmune
9Agilis Biotherapeutics
10Sharp Edge
Unlock 12 + competitors

Trending Companies